Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

Vaccine

Volumn 17, Issue 5, 1999, Pages 497-507

  Berglund, Peter ^a   Fleeton, Marina N ^a   Smerdou, Cristian ^a   Liljeström, Peter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; RECOMBINANT VACCINE; VIRUS NUCLEOPROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HELPER CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REPLICON; SEMLIKI FOREST ALPHAVIRUS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; HEMATOPOIETIC STEM CELLS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; SEMLIKI FOREST VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0033524647     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00224-2     Document Type: Article

References (48)

1. Hirsch V.M., Fuerst T.R., Sutter G., Carroll M.W., Yang L.C., Goldstein S., Piatak M., Elkins W.R., Alvord W.G., Montefiori D.C., Moss B., Lifson J.D. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol. 70:1996;3741-3752.
2. Sutter G., Wyatt L.S., Foley P.L., Bennick J.R., Moss B. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of Vaccinia virus stimulates protective immunity in mice to Influenza virus. Vaccine. 12:1994;53-59.
3. Taylor J, Meignier B, Tartaglia J, Languet B, VanderHoeven J, Franchini G, Trimarchi C, Paoletti E Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine. 13:1995;539-549.
4. Taylor J., Weinberg R., Languet B., Desmettre P., Paoletti E. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine. 6:1988;497-503.
5. Davis N.L., Brown K.W., Johnston R.E. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J Virol. 70:1996;3781-3787.
6. Pugachev K.V., Mason P.W., Shope R.E., Frey T.K. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Virology. 212:1995;587-594.
7. Zhou X., Berglund P., Zhao H., Liljeström P., Jondal M. Generation of cytotoxic and humoral immune responses using non-replicative recombinant Semliki Forest virus. Proc Natl Acad Sci USA. 92:1995;3009-3013.
8. Strauss J.H., Strauss E.G. The Alphaviruses: gene expression, replication and evolution. Microbiol Revs. 58:1994;491-562.
9. Berglund P., Sjöberg M., Atkins G.J., Sheahan B.J., Garoff H., Liljeström P. Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology. 11:1993;916-920.
10. Liljeström P., Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology. 9:1991;1356-1361.
11. Fleeton M., Sheahan B., Gould E., Atkins G., Liljeström P. Protection against louping ill flavivirus infection of mice upon vaccination with recombinant Semliki Forest virus expressing the nonstructural protein NS1. Submitted.
12. Zhou X., Berglund P., Rhodes G., Parker S.E., Jondal M., Liljestrom P. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine. 12:1994;1510-1514.
13. Berglund P., Quesada-Rholander M., Putkonen P., Biberfeld G., Thorstensson R., Liljeström P. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res Hum Retroviruses. 13:1997;1487-1495.
14. Mossman S.P., Bex F., Berglund P., Arthos J., O'Neil S.P., Riley D., Maul D.H., Bruck C., Momin P., Burny A., Fultz P.N., Mullins J.I., Liljeström P., Hoover E.A. Protection against lethal Simian Immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol. 70:1996;1953-1960.
15. Liljeström P., Garoff H. Expression of proteins using Semliki Forest virus vectors. In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Smith J.A., Seidman J.G., Struhl K., editors. Curr Prot Mol Biol. New York: Greene Publishing Associates and Wiley Interscience, 1994. p. 16.20.1-16.20.16.
16. Rhodes G.H., Dwarki V.J., Abai A.M., Felgner J., Felgner P.L., Gromkovski S.H., Parker S.E. Injection of expression vectors containing viral genes induces cellular, humoral and protective immunity. In: Ginsberg H.S., Brown F., Chanock R.M., Lerner R.A., editors. Vaccines 93. Cold Spring Harbor: Cold Spring Harbor Press, 1993. p. 137-141.
17. Liljeström P., Lusa S., Huylebroeck D., Garoff H. In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the 6000-molecular-weight membrane protein modulates virus release. J Virol. 65:1991;4107-4113.
18. Rötzschke O., Falk K., Deres K., Schild H., Norda M., Metzger J., Jung G., Rammensee H.-G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature. 348:1990;252-254.
19. Taswell C. Limiting dilution assay for the determination of imunocompetent cell frequencies. J Immunol. 126:1981;1614-1619.
20. Ulmer J.B., Deck R.R., Dewitt C.M., Donnelly J.J., Liu M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology. 89:1996;59-67.
21. Ulmer J.B., Deck R.R., Dewitt C.M., Fu T.M., Donnelly J.J., Caulfield M.J., Liu M.A. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity. Vaccine. 15:1997;839-841.
22. Doe B., Selby M., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA. 93:1996;8578-8583.
23. Fu T.M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., Liu X., Donnelly J.J., Liu M.A. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol med. 3:1997;362-371.
24. Huang A.Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:1994;961-965.
25. Iwasaki A., Torres C.A., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol. 159:1997;11-14.
26. Gates M.C., Sheahan B.J., Atkins G.J. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice. J Gen Virol. 65:1984;73-80.
27. Kaluza G., Lell G., Reinacher M., Stitz L., Willems W.R. Neurogenic spread of Semliki Forest virus in mice. Arch Virol. 93:1987;97-110.
28. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol. 7:1989;145-173.
29. Feltquate D.M., Heany S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol. 158:1997;2278-2284.
30. Constant S.L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses - the alternative approaches. Ann Rev Immunol. 15:1997;297-322.
31. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
32. Scott P. Selective differentiation of CD4+ T helper cell subsets. Curr Op Immunol. 5:1993;391-397.
33. Wenner C.A., Guler M.L., Macatonia S.E., O'Garra A., Murphy K.M. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol. 156:1996;1442-1447.
34. Brandt E.R., Linnane A.W., Devenish R.J. Expression of IFN A genes in subpopulations of peripheral blood cells. Br J Haematol. 86:1994;717-725.
35. Blackman M.J., Morris A.G. Gamma interferon production and cytotoxicity of spleen cells from mice infected with Semliki Forest virus. J Gen Virol. 65:1984;955-961.
36. Donnelly S.M., Sheahan B.J., Atkins G.J. Long-term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathol Appl Neurobiol. 23:1997;235-241.
37. Caley I.J., Betts M.R., Irlbeck D.M., Davis N.L., Swanstrom R., Frelinger J.A., Johnston R.E. Humoral, mucosal and cellular immunity in response to a Human Immunodeficiency Virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol. 71:1997;3031-3038.
38. Kündig T.M., Kalberer C.P., Hengartner H., Zinkernagel R.M. Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. Vaccine. 11:1993;1154-1158.
39. Hunt L.A., Brown D.W., Robinson H.L., Naeve C.W., Webster R.G. Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J Virol. 62:1988;3014-3019.
40. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine. 15:1997;71-78.
41. Montgomery D.L., Shiver J.W., Leander K.R., Perry H.C., Friedman A., Martinez D., Ulmer J.B., Donnelly J.J., Liu M.A. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:1993;777-783.
42. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
43. Fu T.-M., Friedman A., Ulmer J.B., Liu M.A., Donnelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of Influenza virus nucleoproteins induced by DNA immunization. J Virol. 71:1997;2715-2721.
44. Yap K.L., Ada G.L., McKenzie I.F.C. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 273:1978;238-239.
45. Mozdzanowska K., Furchner M., Washko G., Mozdzanowski J., Gerhard W. A pulmonary Influenza infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that dispaly very low virus-neutralizing activity in vitro. J Virol. 71:1997;4347-4355.
46. Palladino G., Mozdzanowska K., Washko G., Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol. 69:1995;2075-2081.
47. Taylor P.M., Askonas B.A. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology. 58:1986;417-420.
48. Townsend A.R., Rothbard J., Gotch F.M., Bahadur G., Wraith D., McMichael A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:1986;959-968.